Should All Patients With Pancreatic Cancer Receive Chemotherapy Before Surgery?

During the last decade, moderate progress in the treatment of pancreatic ductal adenocarcinoma (PDAC) has been realized with updated chemotherapeutic regimens, advanced operative techniques, and in some cases, targeted genetic-based therapy. Treating patients with borderline resectable or locally…

Read the full article here

Related Articles